Topics AMED continues participation in the "Healthy Longevity Global Competition"



In February 2019, AMED signed a Memorandum of Cooperation (MoC) with the U.S. National Academy of Medicine (NAM) to participate in the Catalyst phase, or the first phase of the "Healthy Longevity Grand Challenge" initiated by the NAM. Since then, AMED has registered a total of 61 research projects from 2020 to 2022 that meet the objectives of this program from among the research projects AMED has supported. There are several proposals that advanced to the Accelerator phase (the second phase of the program) and are receiving support from the sponsors participating in the program.

The program was originally scheduled to run for 3 years, but as the number of participating countries and institutions has increased and the program has been expanding, the NAM, AMED and other participating institutions have come to a unified view that the program should continue for another three years. On this occasion, the name of the program will be also changed to the "Healthy Longevity Global Competition(HLGC)”.

In December 2022, AMED signed a MoC to extend its participation in this program for the next three years, in the expectation that participation in the program will provide AMED and Japanese researchers with the opportunities to explore advanced visions in the field of healthy longevity with other participating Global Collaborators, accelerate the practical application of the research projects, and create novel international research collaboration opportunities.




Last updated 01/25/23